Olivier Clermont
Overview
Explore the profile of Olivier Clermont including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
111
Citations
5182
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Condamine B, Morel-Journel T, Tesson F, Royer G, Magnan M, Bernheim A, et al.
ISME J
. 2024 Dec;
19(1.
PMID: 39665373
Escherichia coli is an increasingly antibiotic-resistant opportunistic pathogen. Few data are available on its ecological and evolutionary dynamics in its primary commensal niche, the vertebrate gut. Using Illumina and/or Nanopore...
2.
Gaborieau B, Vaysset H, Tesson F, Charachon I, Dib N, Bernier J, et al.
Nat Microbiol
. 2024 Nov;
9(11):2847-2861.
PMID: 39482383
Predicting bacteriophage infection of specific bacterial strains promises advancements in phage therapy and microbial ecology. Whether the dynamics of well-established phage-host model systems generalize to the wide diversity of microbes...
3.
Gaborieau B, Delattre R, Adiba S, Clermont O, Denamur E, Ricard J, et al.
J Virol
. 2024 Aug;
98(10):e0111324.
PMID: 39213164
Importance: This study isolated more than 50 phage-resistant mutants from both and conditions, exposing an extra-intestinal pathogenic strain to a single virulent phage. The characterization of these clones revealed several...
4.
Milenkov M, Proux C, Rasolofoarison T, Rakotomalala F, Rasoanandrasana S, Rahajamanana V, et al.
Lancet Microbe
. 2024 Jun;
5(8):100850.
PMID: 38908389
Background: Antimicrobial resistance (AMR) is a major public health threat, affecting not only people but also animals and the environment. The One Health dimension of AMR is well known; however,...
5.
Gschwind R, Petitjean M, Fournier C, Lao J, Clermont O, Nordmann P, et al.
Antimicrob Agents Chemother
. 2024 Mar;
68(4):e0145923.
PMID: 38441061
Beta-lactamase-mediated degradation of beta-lactams is the most common mechanism of beta-lactam resistance in Gram-negative bacteria. Beta-lactamase-encoding genes can be transferred between closely related bacteria, but spontaneous inter-phylum transfers (between distantly...
6.
Sokal A, Royer G, Esposito-Farese M, Clermont O, Condamine B, Laouenan C, et al.
J Infect Dis
. 2024 Jan;
229(6):1679-1687.
PMID: 38214565
Background: Escherichia coli is frequently responsible for bloodstream infections (BSIs). Among digestive BSIs, biliary infections appear to be less severe. Respective roles of host factors, bacterial determinants (phylogroups, virulence, and...
7.
Burgaya J, Marin J, Royer G, Condamine B, Gachet B, Clermont O, et al.
PLoS Genet
. 2023 Aug;
19(8):e1010842.
PMID: 37531401
Escherichia coli is both a highly prevalent commensal and a major opportunistic pathogen causing bloodstream infections (BSI). A systematic analysis characterizing the genomic determinants of extra-intestinal pathogenic vs. commensal isolates...
8.
Bhattacharjee A, Sands K, Mitra S, Basu R, Saha B, Clermont O, et al.
Microbiol Spectr
. 2023 Jun;
11(4):e0521522.
PMID: 37367488
Longitudinal studies of extraintestinal pathogenic Escherichia coli (ExPEC) and epidemic clones of E. coli in association with New Delhi metallo-β-lactamase () in septicaemic neonates are rare. This study captured the...
9.
Royer G, Clermont O, Marin J, Condamine B, Dion S, Blanquart F, et al.
Nat Commun
. 2023 Jun;
14(1):3667.
PMID: 37339949
The intrinsic virulence of extra-intestinal pathogenic Escherichia coli is associated with numerous chromosomal and/or plasmid-borne genes, encoding diverse functions such as adhesins, toxins, and iron capture systems. However, the respective...
10.
Rondinaud E, Clermont O, Petitjean M, Ruppe E, Esposito-Farese M, Nazimoudine A, et al.
J Travel Med
. 2022 Nov;
30(1).
PMID: 36444951
Background: Colistin is an antibiotic of last resort in the management of highly drug-resistant Enterobacterales infections. Travel to some destinations presents a high risk of acquiring multidrug-resistant Enterobacterales, but little...